2010China Modern MedicineRequires access

Efficacy observation of pulmonary invasive fungal infection treated with itraconazole

Wenjun Xu

Open publisher page 0 citations

Abstract

Objective:To compare clinical efficacy of micafungin and itraconazole treatment of pulmonary invasive fungal infections(IPFI).Methods:80 patients in our hospital from January 2007 to February 2010 were divided into micafungin group and itraconazole group according to the different treatment methods,micafungin group 38 cases,itraconazole group 42 cases,15 days for a course of treatment,after two courses compared the clinical efficacy and the incidence of adverse reactions,and make statistical analysis.Results:Itraconazole group markedly effective rate and total effective rate was significantly higher than the micafungin group,two groups were significant different(P0.05),difference of adverse reactions the was not significant between two groups(P0.05).Conclusion:Itraconazole treatment of pulmonary invasive fungal infections is effective,side-effect is small,it should be promoted.

About this research paper

What this paper is about

Objective:To compare clinical efficacy of micafungin and itraconazole treatment of pulmonary invasive fungal infections(IPFI).Methods:80 patients in our hospital from January 2007 to February 2010 were divided into micafungin group and itraconazole group according to the different treatment methods,micafungin group 38 cases,itraconazole group 42 cases,15 days for a course of treatment,after two courses compared the clinical efficacy and the incidence of adverse reactions,and make statistical analysis.Results:Itraconazole group markedly effective rate and total effective rate was significantly higher than the micafungin group,two groups were significant different(P0.05),difference of adverse reactions the was not significant between two groups(P0.05).Conclusion:Itraconazole treatment of pulmonary invasive fungal infections is effective,side-effect is small,it should be promoted.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To compare clinical efficacy of micafungin and itraconazole treatment of pulmonary invasive fungal infections(IPFI).Methods:80 patients in our hospital from January 2007 to February 2010 were divided into micafungin group and itraconazole group according to the different treatment methods,micafungin group 38 cases,itraconazole group 42 cases,15 days for a course of treatment,after two courses compared the clinical efficacy and the incidence of adverse reactions,and make statistical analysis.Results:Itraconazole group markedly effective rate and total effective rate was significantly higher than the micafungin group,two groups were significant different(P0.05),difference of adverse reactions the was not significant between two groups(P0.05).Conclusion:Itraconazole treatment of pulmonary invasive fungal infections is effective,side-effect is small,it should be promoted.

Key concepts: Itraconazole, Micafungin, Medicine, Incidence (geometry), Adverse effect, Internal medicine, Clinical efficacy, Pulmonary infection

Related papers

Back to paper searchBrowse research topicsOriginal source
Efficacy observation of pulmonary invasive fungal infection treated with itraconazole — Research Paper | ScholarLens